AHFS Drug Information PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download AHFS Drug Information PDF full book. Access full book title AHFS Drug Information by American Society of Health-System Pharmacists. Download full books in PDF and EPUB format.

AHFS Drug Information

AHFS Drug Information PDF Author: American Society of Health-System Pharmacists
Publisher:
ISBN: 9781585283804
Category : Clinical pharmacology
Languages : en
Pages : 0

Book Description
Written and published by pharmacists and reviewed by over 500 experts, AHFS Drug Information® (AHFS DI) is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. The only print compendium designated by the US Congress, AHFS DI is also the only reference published by a professional and scientific society - ensuring it is the most authoritative and best-selling reference trusted by pharmacists for 55 years. 700,000 Adverse Drug Events occur every year. The majority of these are preventable. AHFS DI is a must-have resource to have at your fingertips. Its detailed and comprehensive drug monographs deliver valuable information and therapeutic guidelines to even the most complex questions. Don't waste time searching other references when you know you will always find the answer you can trust to be accurate inside-every time. Don't you owe it to yourself, your profession, and your patients? Inside find peer-reviewed monographs that cover: Expanded and revised content, featuring critical new monograph updates every year Interactions, adverse reactions, cautions, and more Therapeutic recommendations supported by evidence from primary research Preparations, chemistry, and stability Pharmacology and pharmacokinetics Prescription, OTC, ophthalmic and dermatologic drugs Extensive, off-label uses and dosing options Vaccines and other immunizing agents As always, there is a strong focus on safe and effective use of drugs. Hundreds of monographs have been updated for FDA's MedWatch alerts, risk evaluation mitigation strategies (REMS), and other critical safety information. Be sure to stay up to date with the latest medwatch alerts, new drug monographs, and updates, with your online access to AHFS Drug Information. Get access with the username and password found within the preface of the print book.

AHFS Drug Information

AHFS Drug Information PDF Author: American Society of Health-System Pharmacists
Publisher:
ISBN: 9781585283804
Category : Clinical pharmacology
Languages : en
Pages : 0

Book Description
Written and published by pharmacists and reviewed by over 500 experts, AHFS Drug Information® (AHFS DI) is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. The only print compendium designated by the US Congress, AHFS DI is also the only reference published by a professional and scientific society - ensuring it is the most authoritative and best-selling reference trusted by pharmacists for 55 years. 700,000 Adverse Drug Events occur every year. The majority of these are preventable. AHFS DI is a must-have resource to have at your fingertips. Its detailed and comprehensive drug monographs deliver valuable information and therapeutic guidelines to even the most complex questions. Don't waste time searching other references when you know you will always find the answer you can trust to be accurate inside-every time. Don't you owe it to yourself, your profession, and your patients? Inside find peer-reviewed monographs that cover: Expanded and revised content, featuring critical new monograph updates every year Interactions, adverse reactions, cautions, and more Therapeutic recommendations supported by evidence from primary research Preparations, chemistry, and stability Pharmacology and pharmacokinetics Prescription, OTC, ophthalmic and dermatologic drugs Extensive, off-label uses and dosing options Vaccines and other immunizing agents As always, there is a strong focus on safe and effective use of drugs. Hundreds of monographs have been updated for FDA's MedWatch alerts, risk evaluation mitigation strategies (REMS), and other critical safety information. Be sure to stay up to date with the latest medwatch alerts, new drug monographs, and updates, with your online access to AHFS Drug Information. Get access with the username and password found within the preface of the print book.

AHFS Drug Information

AHFS Drug Information PDF Author: Gerald K. McEvoy
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 2296

Book Description


AHFS Drug Information 2003

AHFS Drug Information 2003 PDF Author:
Publisher:
ISBN:
Category : Clinical pharmacology
Languages : en
Pages : 3772

Book Description


AHFS Drug Information 2004

AHFS Drug Information 2004 PDF Author: Gerald K. McEvoy
Publisher:
ISBN: 9781585280582
Category : Clinical pharmacology
Languages : en
Pages : 0

Book Description


Ahfs Drug Information 2020

Ahfs Drug Information 2020 PDF Author: American Society of Health System Pharmacists
Publisher:
ISBN: 9781585286119
Category :
Languages : en
Pages : 840

Book Description


AHFS Drug Information

AHFS Drug Information PDF Author: AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS.
Publisher:
ISBN: 9781585287215
Category : Clinical pharmacology
Languages : en
Pages : 0

Book Description


AHFS Drug Information 2002

AHFS Drug Information 2002 PDF Author: American Society of Health-System Pharmacists
Publisher:
ISBN: 9781585280339
Category : Clinical pharmacology
Languages : en
Pages : 0

Book Description


Essentials 2004-2005

Essentials 2004-2005 PDF Author: Gerald K. McEvoy
Publisher:
ISBN: 9781585281039
Category : Medical
Languages : en
Pages : 1544

Book Description


AHFS Drug Information 2015

AHFS Drug Information 2015 PDF Author: ASHP
Publisher:
ISBN: 9781585284184
Category : Clinical pharmacology
Languages : en
Pages : 0

Book Description
With extensive updated information on everything from treatment of hypertension to HIV, AHFS Drug Information(r), 2015 Edition is a necessary addition to your pharmacy s resources. It contains nearly 85,000 total references and is reviewed by over 500 professionals, helping you to protect your patients and your business. The only print compendium designated by the U.S. Congress, AHFS DI 2015 is also the only reference published by a professional and scientific society - ensuring it is the most authoritative and best-selling reference trusted by pharmacists for 57 years. AHFSI DI contains the most trustworthy drug information available - all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. Updates for this edition include: Expanded and revised content throughout, featuring critical new monograph updates every year Important updated monographs and references related to revised therapeutic guidelines, including recommendations for the treatment of hypertension, elevated cholesterol, and HIV infections Newly published information on breakthrough oncology drugs recently approved as part of the FDA s accelerated approval program Dedicated coverage to orphan products Interactions, adverse reactions, cautions, and more Therapeutic recommendations supported by evidence from primary research Preparations, chemistry, and stability Pharmacology and pharmacokinetics Prescription and OTC drugs Extensive off-label uses and dosing options Vaccines and other immunizing agents "

AHFS Drug Information 2022

AHFS Drug Information 2022 PDF Author: ASHP
Publisher:
ISBN: 9781585286843
Category : Medical
Languages : en
Pages : 0

Book Description
AHFS Drug Information® 2022 contains the most dependable drug information available-all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice. Updates in the new edition: The latest information on COVID-19 vaccines and COVID-19 monoclonal antibodies available under FDA Emergency Use Authorizations (EUAs), including clinical considerations from the US Centers for Disease Control and Prevention (CDC), and National Institutes of Health (NIH). Information on patient selection and appropriate use of corticosteroids in the management of COVID-19 based on recent guidelines from NIH and the World Health Organization (WHO). Contemporary issues such as anticoagulant reversal strategies and use of direct oral anticoagulants versus warfarin for treatment of venous thromboembolism or atrial fibrillation. Current best practices such as reversal of neuromuscular blocking agents for prevention of postoperative residual neuromuscular blockade. Newly published information on breakthrough oncology drugs approved as part of the FDA's accelerated approval program. Expanded content on off-label uses, real-world data, and long-term clinical data. Updated information on pharmacogenomic considerations based on recommendations from the Clinical Pharmacogenetics Implementation Consortium (CPIC). Addition of 51 new molecular entities (NMEs) or new therapeutic biological products approved since January 2021.